EUVIMEDEUVIMED entdecken
Crossref

The Value of ROH Metrics for Predicting Morbidity: Insights From a Large Cohort Analysis of Chromosomal Microarray

Lena Sagi-Dain iD, Michal Levy, Reut Matar, Sarit Kahana, Ifaat Agmon-Fishman, Cochava Klein, Merav Gurevitch, Lina Basel-Salmon, Idit Maya

Clinical Genetics · 2025

DOI: 10.1111/cge.14686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Lena Sagi-Dain und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Institute, Carmel Medical Center, Affiliated to the Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology,…. Hauptthemen laut MEDLINE: Homozygote, Microarray Analysis, Chromosomes, Human. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective cohort study aimed to define the optimal Regions of Homozygosity (ROH) size cut‐offs for prediction of morbidity, based on 13 483 Chromosomal Microarray Analyses (CMA). Receiver operating characteristic (ROC) curves were generated, and area under the curve (AUC) was used to assess the predictive capability of total ROH percentage (TRPS), ROH number and ROH segment size in distinguishing between healthy ( n =6,196) and affected ( n =6,839) cohorts. The metrics were examined for telomeric and interstitial segments, distinct TRPS categories, and across different ancestral origins. ROH segments were identified in 13 035 samples (96.7%), encompassing 66 710 ROH segments. Significant differences in TRPS and ROH segment size were observed between healthy and affected cohorts ( p =0.012 and p < 0.001, respectively). However, no clinically significant thresholds could be established based on ROC curves for TRPS and ROH number per sample, as well as for ROH size (AUC 0.64, 0.55, and 0.62, respectively, Figure 1). The same was noted for telomeric versus interstitial locations, various origins, and subcategories of TRPS. In conclusion, this study highlights the complexity of ROH interpretation and emphasizes the importance of tailored reporting strategies in clinical practice. Our findings underscore the need for context‐specific reporting guidelines and further research, particularly in consanguineous populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HomozygoteMicroarray AnalysisChromosomes, HumanHumansROC CurveRetrospective StudiesMorbidityFemaleMaleCohort StudiesOligonucleotide Array Sequence Analysis

Stichwörter der Autor:innen

chromosomal microarray analysisdynamic reporting thresholdsregions of homozygositytotal sample ROH percentageuniparental Disomy (UPD)

Autor:innen und Institutionen

  • Genetics Institute, Carmel Medical Center, Affiliated to the Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
  • Recanati Genetics Institute, Beilinson Hospital, Rabin Medical Center, Petach Tikva, Israel.
  • School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Pediatric Genetics Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel; Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva, Israel.

ORCID-Profile: Lena Sagi-Dain

Zitieren

APA

Sagi-Dain, L., Levy, M., Matar, R., Kahana, S., Agmon-Fishman, I., Klein, C., Gurevitch, M., Basel-Salmon, L., & Maya, I. (2025). The Value of ROH Metrics for Predicting Morbidity: Insights From a Large Cohort Analysis of Chromosomal Microarray. Clinical Genetics. https://doi.org/10.1111/cge.14686

Vancouver

Sagi-Dain L, Levy M, Matar R, Kahana S, Agmon-Fishman I, Klein C, et al. The Value of ROH Metrics for Predicting Morbidity: Insights From a Large Cohort Analysis of Chromosomal Microarray. Clinical Genetics. 2025. doi:10.1111/cge.14686

BibTeX
@article{SagiDain2025,
  author = {Sagi-Dain, Lena and Levy, Michal and Matar, Reut and Kahana, Sarit and Agmon-Fishman, Ifaat and Klein, Cochava and Gurevitch, Merav and Basel-Salmon, Lina and Maya, Idit},
  title = {The Value of ROH Metrics for Predicting Morbidity: Insights From a Large Cohort Analysis of Chromosomal Microarray},
  journal = {Clinical Genetics},
  year = {2025},
  doi = {10.1111/cge.14686}
}
Kostenlos starten →